cro pois benefit biopharma outsourc syneo
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jan
estim dec
price data jan
rate updat jan
currenc amount express
methodolog valu compani
transfer coverag major late-stag contract
research organ thesi industri
remain continu outsourc biotechnolog
pharmaceut compani drive growth larger
global help design conduct clinic trial
maintain narrow moat stabl trend rate
syneo health icon downgrad
market leader iqvia moat narrow wide
posit clinic research data space
four narrow-moat syneo look
attract territori note
high uncertainti rate due high
debt load merger inc research
compani
iqvia moat downgrad lower fair valu
estim continu view share
fairli valu believ intang asset
switch cost underpin narrow econom moat
iqvia longer confid firm earn
excess return least year compani return
invest capit significantli diminish follow
merger quintil im health
high confid firm maintain
monopolist hold aggreg patient data
decad contract research organ softwar
compani increasingli engag patient data
begin play increas role clinic research
commerci believ
technolog interoper could eventu lower
barrier access patient data
maintain fair valu estim per share
syneo health result merger inc
research inventiv health lacklust growth
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
iqvia result merger quintil lead global contract
research organ im health lead healthcar data
analyt provid cro segment focus primarili provid
outsourc late-stag clinic trial pharmaceut devic
technolog servic client healthcar industri includ
pharmaceut compani provid payer policymak
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
quarter follow merger due
cancel commerci segment final stabil
like compani focu integr deal
drive revenu clinic commerci
busi howev compani took signific debt
merger could constrain capit alloc
strategi near term expect syneo complet
fiscal total debt time adjust
ebitda debt matur push
beyond
rais icon fair valu estim
per share due slightli higher growth expect
near term expect icon continu diversifi
revenu base away client concentr risk
top client maintain focu lucr
partnership larg biopharma client share remain
overvalu
acquisit strategi solid execut evidenc
higher oper margin higher adjust return
invest capit compar peer
lower health fair valu estim
per share re-examin long-term cost
assumpt view share fairli valu still
model robust top-lin growth continu margin
improv note compani slightli
higher exposur lower-margin staf solut
peer expect manag roll plan
integr symphoni data clinic research
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
